These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 2069400)
21. [Clinical usefulness of tumor markers for the diagnosis of ovarian cancer]. Ito K; Udagawa Y; Nozawa S Gan To Kagaku Ryoho; 1992 Oct; 19(12):1964-70. PubMed ID: 1417005 [TBL] [Abstract][Full Text] [Related]
22. [Clinical evaluation of various tumor markers in pleural effusion and in the serum]. Jibiki K; Abe Y; Takeda M; Iwachika C; Odagiri E; Demura R; Demura H Gan No Rinsho; 1989 Aug; 35(9):991-8. PubMed ID: 2769951 [TBL] [Abstract][Full Text] [Related]
23. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer. Koelbl H; Schieder K; Neunteufel W; Bieglmayer C Neoplasma; 1989; 36(4):473-8. PubMed ID: 2770933 [TBL] [Abstract][Full Text] [Related]
24. [Studies on CA 125, CA 19-9, TPA and IAP as tumor markers in patients with ovarian cancer]. Negishi Y; Furuno K; Sano Y; Hirata T; Utsunomiya A; Nakajima H; Okabe K; Shimizu K; Akiya K; Fujiwara Y Gan No Rinsho; 1985 May; 31(6 Suppl):655-63. PubMed ID: 2993692 [TBL] [Abstract][Full Text] [Related]
25. Serological studies on CEA, CA 19-9, STn and SLX in colorectal cancer. Sato T; Nishimura G; Nonomura A; Miwa K; Miyazaki I Hepatogastroenterology; 1999; 46(26):914-9. PubMed ID: 10370638 [TBL] [Abstract][Full Text] [Related]
26. Pre-operative serum levels of sialyl Tn antigen predict liver metastasis and poor prognosis in patients with gastric cancer. Nakagoe T; Sawai T; Tsuji T; Jibiki M; Nanashima A; Yamaguchi H; Yasutake T; Ayabe H; Arisawa K; Ishikawa H Eur J Surg Oncol; 2001 Dec; 27(8):731-9. PubMed ID: 11735169 [TBL] [Abstract][Full Text] [Related]
27. [CA 125 (cancer antigen 125), a new tumor associated antigen recognized by monoclonal antibody]. Suzuki H; Teshima K; Noda K Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2719-23. PubMed ID: 6594978 [TBL] [Abstract][Full Text] [Related]
28. [Significance of CA 125 antigen levels in patients with ovarian cancer]. Shimizu Y; Fujiwara H; Akagaki E; Hirota K; Kono M; Irie T; Miura S; Okudaira Y Gan To Kagaku Ryoho; 1986 Jan; 13(1):46-52. PubMed ID: 3455806 [TBL] [Abstract][Full Text] [Related]
29. [A clinical evaluation of the CA 72-4 serum level as a possible tumor marker]. Jibiki K; Takeda M; Abe H; Ito M; Odagiri E; Demura R; Demura H; Takizawa K Gan No Rinsho; 1990 Oct; 36(12):2146-52. PubMed ID: 2232183 [TBL] [Abstract][Full Text] [Related]
30. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary. Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350 [TBL] [Abstract][Full Text] [Related]
32. [Tumor markers in uterine cancers]. Fukasawa I; Kousaka N; Kun Z; Inaba N Gan To Kagaku Ryoho; 2002 Feb; 29(2):333-40. PubMed ID: 11865645 [TBL] [Abstract][Full Text] [Related]
33. [Clinical significance of galactosyltransferase associated with tumor (GAT), a new tumor marker for ovarian cancer--with special reference to the discrimination between ovarian cancer and endometriosis]. Nozawa S; Udagawa Y; Ito K; Nishimura H; Yakushiji M; Shiota M; Noda K; Yajima M; Ohkura H; Murae M Gan To Kagaku Ryoho; 1994 Mar; 21(4):507-16. PubMed ID: 8129392 [TBL] [Abstract][Full Text] [Related]
34. Preoperative serum levels of sialyl Lewis(a), sialyl Lewis(x), and sialyl Tn antigens as prognostic markers after curative resection for colorectal cancer. Nakagoe T; Sawai T; Tsuji T; Jibiki MA; Nanashima A; Yamaguchi H; Yasutake T; Kurosaki N; Ayabe H; Arisawa K Cancer Detect Prev; 2001; 25(3):299-308. PubMed ID: 11425272 [TBL] [Abstract][Full Text] [Related]
35. [A study of localizations and serum data; four tumor markers (CA125, CA19-9, CEA and TPA) in ovarian cancers]. Kataoka A; Yakushiji M Nihon Gan Chiryo Gakkai Shi; 1990 Jan; 25(1):47-54. PubMed ID: 2157782 [TBL] [Abstract][Full Text] [Related]
36. Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix. Juang CM; Wang PH; Yen MS; Lai CR; Ng HT; Yuan CC Gynecol Oncol; 2000 Jan; 76(1):103-6. PubMed ID: 10620449 [TBL] [Abstract][Full Text] [Related]
37. [Clinical significance of present tumor markers]. Ohkura H Gan To Kagaku Ryoho; 1993 May; 20(7):843-9. PubMed ID: 7683865 [TBL] [Abstract][Full Text] [Related]
38. Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis. Sasaki M; Morita T; Hoso M; Nakanuma Y; Tanimura H Hepatology; 1996 Feb; 23(2):258-63. PubMed ID: 8591850 [TBL] [Abstract][Full Text] [Related]
39. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma. Hasholzner U; Baumgartner L; Stieber P; Meier W; Hofmann K; Fateh-Moghadam A Anticancer Res; 1994; 14(6B):2743-6. PubMed ID: 7532929 [TBL] [Abstract][Full Text] [Related]
40. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies]. Gang Y; Adachi I; Ohkura H; Yamamoto H; Mizuguchi Y; Abe K Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]